N-[4-[[(3S,3aR,6S,6aR)-3-[[4-(3-fluorophenyl)pyrimidin-2-yl]amino]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]sulfamoyl]phenyl]acetamide

ID: ALA5191875

Max Phase: Preclinical

Molecular Formula: C24H24FN5O5S

Molecular Weight: 513.55

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1ccc(S(=O)(=O)N[C@H]2CO[C@H]3[C@@H]2OC[C@@H]3Nc2nccc(-c3cccc(F)c3)n2)cc1

Standard InChI:  InChI=1S/C24H24FN5O5S/c1-14(31)27-17-5-7-18(8-6-17)36(32,33)30-21-13-35-22-20(12-34-23(21)22)29-24-26-10-9-19(28-24)15-3-2-4-16(25)11-15/h2-11,20-23,30H,12-13H2,1H3,(H,27,31)(H,26,28,29)/t20-,21-,22+,23+/m0/s1

Standard InChI Key:  FWUNAYRNISPLQE-MYDTUXCISA-N

Associated Targets(Human)

JMJD1C Tbio Probable JmjC domain-containing histone demethylation protein 2C (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM3B Tbio Lysine-specific demethylase 3B (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 513.55Molecular Weight (Monoisotopic): 513.1482AlogP: 2.17#Rotatable Bonds: 7
Polar Surface Area: 131.54Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.20CX Basic pKa: 4.73CX LogP: 2.05CX LogD: 2.05
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.44Np Likeness Score: -1.50

References

1. He X, Zhang H, Zhang Y, Ye Y, Wang S, Bai R, Xie T, Ye XY..  (2022)  Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).,  231  [PMID:35101649] [10.1016/j.ejmech.2022.114143]

Source